Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAM-101 in Dry Eye Secondary to Graft vs Host Disease
NCT03414645Phase 2Completed
- Sponsor
- Cambium Bio
- Start
- May 2018
- Primary completion
- Dec 2019
- Modality
- Recombinant Proteins and Enzymes, Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of CAM-101 in dry eye disease (DED), sponsored by Cambium Bio. Started May 2018; status: completed.
02
Drugs
CAM-101
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT03414645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03414645.